# OnCo record nct06177041 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06177041/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06177041", "NCT06177041" ;
  schema:name "M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma"@en ;
  schema:description "A phase 3 trial testing M108 in gastric & gastro-oesophageal junction cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06177041/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06177041> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-12-25" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:drugs <https://onco.cc/drugs/m108/> .